Legend Biotech Corp ADR (LEGN) plunge -2.61% in a week: will this be a lucky break through?

Shaun Noe

Legend Biotech Corp ADR (NASDAQ: LEGN) open the trading on Wednesday, with a bit cautious approach as it glided -2.67% to $31.17, before settling in for the price of $32.03 at the close. Taking a more long-term approach, LEGN posted a 52-week range of $27.34-$45.30.

The Healthcare sector firm’s twelve-monthly sales growth has been 0.82% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was 0.82%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -57.99%. This publicly-traded company’s shares outstanding now amounts to $184.57 million, simultaneously with a float of $180.77 million. The organization now has a market capitalization sitting at $5.75 billion. At the time of writing, stock’s 50-day Moving Average stood at $32.84, while the 200-day Moving Average is $34.69.

Legend Biotech Corp ADR (LEGN) Ownership Facts and Figures

Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. Legend Biotech Corp ADR’s current insider ownership accounts for 2.06%, in contrast to 44.80% institutional ownership.

Legend Biotech Corp ADR (LEGN) Earnings and Revenue Records

Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.0 per share during the current fiscal year.

Legend Biotech Corp ADR’s EPS decrease for this current 12-month fiscal period is -57.99% and is forecasted to reach 0.45 in the upcoming year.

Legend Biotech Corp ADR (NASDAQ: LEGN) Trading Performance Indicators

Let’s observe the current performance indicators for Legend Biotech Corp ADR (LEGN). It’s Quick Ratio in the last reported quarter now stands at 4.57. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 7.22.

In the same vein, LEGN’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.77, a figure that is expected to reach -0.05 in the next quarter, and analysts are predicting that it will be 0.45 at the market close of one year from today.

Technical Analysis of Legend Biotech Corp ADR (LEGN)

[Legend Biotech Corp ADR, LEGN] recent stats showed that its last 5-days Average volume was superior the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 33.92% While, its Average True Range was 36.44.

Raw Stochastic average of Legend Biotech Corp ADR (LEGN) in the period of the previous 100 days is set at 8.16%, which indicates a major fall in contrast to 35.06% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 1.23 that was lower than 1.36 volatility it exhibited in the past 100-days period.

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.